Skip to Content
Merck
CN

A9938

Sigma-Aldrich

3-Amino-1,2,4-benzotriazine 1,4-dioxide

Synonym(s):

SR-4233, TPZ, Tirapazamine

Sign Into View Organizational & Contract Pricing

Select a Size


About This Item

Empirical Formula (Hill Notation):
C7H6N4O2
CAS Number:
Molecular Weight:
178.15
MDL number:
UNSPSC Code:
12352103
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

storage temp.

2-8°C

SMILES string

Nc1n[n+]([O-])c2ccccc2[n+]1[O-]

Biochem/physiol Actions

Hypoxia-activated antineoplastic agent.

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M A Baker et al.
Cancer research, 48(21), 5947-5952 (1988-11-01)
The metabolism of SR 4233 (3-amino-1,2,4-bentotriazine-1,4-dioxide), recently reported as highly toxic to hypoxic cells in vitro, was studied by using suspensions of Chinese hamster ovary cells. The rates of formation of two known reduction products, the 1-oxide and the unoxygenated
Yvette M Delahoussaye et al.
Biochemical pharmacology, 65(11), 1807-1815 (2003-06-05)
To improve the potency of the hypoxic cytotoxin tirapazamine (TPZ), we have constructed an analog, SN26955, with the TPZ moiety attached to an acridine chromophore to target the drug to DNA. The underlying reason for this is our previous finding
Mustafa Birincioglu et al.
Journal of the American Chemical Society, 125(38), 11607-11615 (2003-09-18)
Tirapazamine is a bioreductively activated DNA-damaging agent that selectively kills the hypoxic cells found in solid tumors. This compound shows clinical promise and is currently being examined in a variety of clinical trials, including several phase III studies. It is
Ming Yao et al.
Scientific reports, 11(1), 4020-4020 (2021-02-19)
Tumor tissue contains a continuous distribution of static and dynamically changing oxygen environments with levels ranging from physiologically normal oxygen down to anoxia. However, in vitro studies are often performed under oxygen levels that are far higher than those found

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service